Hyperlipidemia in rheumatoid arthritis patients in Saudi Arabia. Correlation with C-reactive protein levels and

Suzan M Attar1

  • 1Department of Internal Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia. E-mail. suzan_attar@hotmail.com.

Insights

Hyperlipidemia is prevalent in Saudi Arabian rheumatoid arthritis (RA) patients, significantly linked to elevated C-reactive protein (CRP) and disease activity. This highlights the need for increased awareness of lipid disorders in active RA.

Area of Science:

  • Rheumatology
  • Cardiovascular Medicine
  • Clinical Biochemistry

Background:

  • Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with an increased risk of cardiovascular complications.
  • Hyperlipidemia is a known risk factor for cardiovascular disease, but its prevalence and associations in RA patients in Saudi Arabia require further investigation.

Purpose of the Study:

  • To determine the prevalence of hyperlipidemia in rheumatoid arthritis patients in Saudi Arabia.
  • To investigate the relationship between hyperlipidemia, C-reactive protein (CRP) levels, and disease activity in these patients.

Main Methods:

  • A cross-sectional study was conducted on 180 RA patients at King Abdulaziz University Hospital, Saudi Arabia.
  • Lipid profiles were measured after overnight fasting.
  • Associations between lipid profiles, CRP levels, and disease activity (28-Joint Disease Activity Score) were analyzed.

Main Results:

  • A high prevalence of hyperlipidemia was observed, with elevated total cholesterol in 55.1% and low-density lipoprotein cholesterol in 51.2% of patients.
  • A significant association was found between increased total cholesterol and higher CRP levels (p=0.002).
  • A positive correlation was detected between total cholesterol and RA disease activity (r=0.23, p=0.036).

Conclusions:

  • Hyperlipidemia is common in Saudi RA patients and significantly associated with elevated CRP levels and disease activity.
  • These findings underscore the importance of monitoring lipid profiles in RA patients, particularly during periods of active disease.
  • Increased awareness among healthcare professionals is crucial for managing hyperlipidemia in active RA.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
781
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
871
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
602
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.1K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.0K